Paraprotein News and Research

RSS
Two immunotherapy approaches for multiple myeloma show hope

Two immunotherapy approaches for multiple myeloma show hope

SkylineDx's MMprofiler receives CE-IVD certification

SkylineDx's MMprofiler receives CE-IVD certification

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Revlimid clinical data in newly diagnosed multiple myeloma presented

Revlimid clinical data in newly diagnosed multiple myeloma presented